http://www.amarantus.com/about/alzheimers-disease-

http://www.amarantus.com/about/alzheimers-dis...ostics-sab

Jeffrey Cummings, MD
Robert A. Stern, Ph.D.
Paula T. Trzepacz, M.D.

http://www.anavex.com/about-us/leadership/
Scientific Advisory Board
Abraham Fisher, PhD
Jeffrey Cummings, MD
Paul Aisen, MD

http://www2.kenes.com/adpd/info/Pages/WelcometoADPD.aspx
Abraham Fisher, PhD - Co-Founding Chairman and President
INTERNATIONAL FACULTY
Colin L. Masters (u should know who he is)
Reisa Sperling,

https://www.facebook.com/fattahneuroscience/a...e_internal
Trails - A4 Reisa Sperling
Technologies and Development - Amarantus
BRAIN Initiative

http://act-ad.org/about-us/science-advisory-board/
http://act-ad.org/resources/q-anavex/
Jeffrey Cummings, MD
Paul Aisen, MD
Reisa Sperling, M.D.

Coalition of Sponsors - Jeffrey Cummings, MD accociated w/ all of them
Anavex - http://act-ad.org/resources/q-anavex/
Anavir - Jeffrey Cummings, MD Advisory committee
Janssen
Merck
Lilly
Novartis
Biogen Idec.


http://www.adcs.org/Default.aspx
Paul S. Aisen M.D.
Director, Alzheimer's Disease Cooperative Study
"The National Institute on Aging (NIA), the lead institute within NIH for Alzheimer’s research, announced the award on Jan. 14, 2013. The ADCS will receive $11M in fiscal year 2013, and the effort could total as much as $55M over the five years of the project. The consortium, coordinated by the University of California, San Diego and led by Paul Aisen, M.D."
http://www.bioprocessonline.com/doc/nih-suppo...ments-0001


ADCS INVESTIGATORS
Robert A. Stern, Ph.D.
Reisa Sperling, M.D.

ADCS STEERING COMMITTEE MEMBERS
Robert A. Stern, Ph.D.
Reisa Sperling, M.D.

Connect Study
Noble Study - Robert A. Stern, Ph.D. is conducting a study called the NOBLE study funded by the National Institute of Health and the Toyama Chemical Co. in Japan at Boston University
A4 Study - Reisa Sperling, M.D. (Fattah Neuroscience Initiative - Useful Links - Trials)
DIAN Study - Paul Aisen, MD
SNIFF Study - This study is on a temporary enrollment hold. This study is being conducted by the Alzheimer’s Disease Cooperative Study (ADCS) through a grant from the National Institute on Aging (NIA), one of the National Institutes of Health (NIH).


Associate Editors
Jeffrey L. Cummings, M.D.
Robert Stern, Ph.D.
Paula T. Trzepacz, M.D.
http://neuro.psychiatryonline.org/neuro_editorialboard


ANPA
Fellows – 2000
Jeffrey L. Cummings, M.D. *Past President

Fellows – 2001
Robert A. Stern, Ph.D.
Paula T. Trzepacz, M.D. *Past President
http://www.anpaonline.org/fellows


http://www.medscape.com/public/bios/ed-neurology
Editorial Board — Medscape Neurology
Jeffrey Cummings, MD,
has disclosed the following relevant financial relationships:
Serve(d) as a director, officer, partner, employee, advisor, consultant, or trustee for: ACADIA Pharmaceuticals Inc., Adamas Pharmaceuticals Corporation; Anavex; Avanir Pharmaceuticals; Boehringer Ingelheim; Bristol-Myers Squibb Company; Eisai Inc.; EnVivo; Genentech, Inc.; Eli Lilly and Company; Lundbeck; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Otsuka Pharmaceutical Co., Ltd.; Pfizer Inc.; Prana Biotechnology Limited; QR Pharma; Resverlogix; Roche; Sonexa Therapeutics, Inc.; Suven; Takeda Pharmaceuticals North America; Toyoma Chemical; GE Healthcare; MedAvante, Inc.
Owns stock in: Adamas Pharmaceuticals Corporation; Prana; Sonexa Therapeutics, Inc.; MedAvante, Inc.; Neurotrax; Neurokos
Received research grant from: Avid Radiopharmaceuticals; Teva Pharmaceuticals


Who do you think big and small Pharma's are going to run to for validation of their patient population in their clinical trials?
Don't forget who wrote that Alzheimer's R&D suffers as trial failure rate hits an 'astounding' 99.6%
http://alzres.com/content/6/4/3

And as an AMBS SAB member what do you think Dr. Cummings is going to recommend for clinical trials. Now providing AMBS, LymPro and the Assays "work". Which would then beg the question, if they didn't work, why on earth would The 4 Top experts in the world be willing to associate themselves with AMBS and use Lympro for their trails? I mean don't you think they would understand the science before attaching their reputations to AMBS?

Pg. 26, yeah, I believe the reference was to this "small" biotech!
http://pcgadvisory.com/wp-content/uploads/201...n-9-14.pdf

Yeah, so for a 3rd time, I will say we've cornered the market. And no, it doesn't show in the share price...yet.

Cheers